RA Capital Healthcare Fund LP, Director, 10% Owner at Acrivon Therapeutics, Inc. (ACRV), bought 3,815,802 shares at $12.50 ($42.4M) on 2022-11-17, disclosed to the SEC on 2022-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 426,302 | $0 | 0.0% |
| 2 | $12.50 | 3,389,500 | $42.4M | 100.0% |
| Total | $11.10 avg | 3,815,802 | $42.4M | 100% |
| Filing → |
| FULC | SELL | 2025-12-10 | $116.8M | — | Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |